The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D11 | Other dermatological preparations | |
| 3 | D11A | Other dermatological preparations | |
| 4 | D11AH | Agents for dermatitis, excluding corticosteroids | |
| 5 | D11AH06 |
| Active Ingredient | Description | |
|---|---|---|
| Crisaborole |
Crisaborole is an anti-inflammatory benzoxaborole phosphodiesterase-4 (PDE4) inhibitor that suppresses secretion of certain cytokines, such as tumour necrosis factor-α (TNF-α), interleukins (IL-2, IL-4, IL-5), and interferon gamma (IFNγ), and improves skin barrier function as measured by transepidermal water loss (TEWL). It is used for treatment of mild to moderate atopic dermatitis in adults and paediatric patients. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| EUCRISA Ointment | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| STAQUIS Ointment | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
